MGI Tech Co., Ltd. (SHA:688114)

China · Delayed Price · Currency is CNY

49.90

+0.86 (1.75%)

At close: Jun 18, 2026

-23.97% (1Y)

Market Cap	20.59B -31.1%
Revenue (ttm)	2.90B -1.9%
Net Income	-158.02M
EPS	-0.39
Shares Out	412.53M
PE Ratio	n/a
Forward PE	66.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,010,015
Open	49.04
Previous Close	49.04
Day's Range	48.60 - 50.70
52-Week Range	44.88 - 82.88
Beta	0.29
Analysts	Buy
Price Target	67.10 (+34.47%)
Earnings Date	Aug 21, 2026

About MGI Tech

MGI Tech Co., Ltd. engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally. Its products include sequencers, such as genetic sequencers, sequencing reagents, library prep kits multiplex immunofluorescence reagent staining sets, and bioinformatics analysis; lab automation products comprising sample pretreatment products, sample preparation platforms, and integrated testing pl... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2016

Employees 2,195

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688114

Full Company Profile

Financial Performance

In 2025, MGI Tech's revenue was 2.78 billion, a decrease of -7.73% compared to the previous year's 3.01 billion. Losses were -222.14 million, -63.03% less than in 2024.

Financial Statements

Analyst Summary

According to 10 analysts, the average rating for 688114 stock is "Buy." The 12-month stock price target is ¥67.10, which is an increase of 34.47% from the latest price.

Price Target

¥67.10

(34.47% upside)

Analyst Consensus: Buy

Stock Forecasts